-
October 27, 2009
Thyroid cancer a risk after childhood cancer
NEW YORK (Reuters Health) - Childhood cancer survivors are 18 times more likely to develop thyroid cancer than the general population, UK researchers report.
-
June 2, 2009
Few cancer breakthroughs at major meeting
ORLANDO, Fla. (Reuters) - This year's meeting of the American Society of Clinical Oncology, a traditional showcase for advances in cancer treatment, has been disappointingly thin on major breakthroughs.
-
April 22, 2009
Wine may improve lymphoma survival
NEW YORK (Reuters Health) - Drinking wine, but not beer or liquor, may improve survival in patients with non-Hodgkin lymphoma (NHL), a type of blood cancer involving the lymph nodes, according to research reported at the American Association for Cancer Research annual meeting in Denver this week.
-
February 5, 2009
Some workplaces may alter cancer risk
NEW YORK (Reuters Health) - The occupation or industry in which one works may either increase or decrease risk for non-Hodgkin's lymphoma, an immune system cancer often found in middle-aged adults.
-
February 4, 2009
Celiac disease linked to high risk of lymphoma
NEW YORK (Reuters Health) - Analysis of data from a Swedish cancer registry shows a more than 5-fold increased risk of non-Hodgkin lymphoma in patients with celiac disease, but the risk is steadily decreasing, and is less than half of what it was 40 years ago.
-
December 15, 2008
Diabetes may be linked to risk of lymphoma
NEW YORK (Reuters Health) - More cases of blood cancers classified as non-Hodgkin's lymphoma, or NHL, seem to occur among people with diabetes than those without, researchers report.
-
December 10, 2008
Roche says studies show its drugs help breast cancer
ZURICH (Reuters) - New data shows that three drugs made by Roche Holding AG help patients with breast cancer live longer or remain disease-free for longer, the Swiss drugmaker said Wednesday.
-
December 8, 2008
Genentech drug boosts leukemia patient survival
LOS ANGELES (Reuters) - A combination of Genentech Inc's cancer drug Rituxan and chemotherapy reduces by 41 percent the risk of death or cancer progression, compared with chemotherapy alone, for patients with a common form of leukemia, the company said on Saturday.
-
November 25, 2008
Cancer rates and cancer-related deaths drop in U.S.
NEW YORK (Reuters Health) - For the first time ever, the overall cancer incidence and death rates have declined for men and women in the United States, according to an annual report released Tuesday by the American Cancer Society, the National Cancer Institute, and other groups.
-
October 10, 2008
Cancer common after liver transplantation
NEW YORK (Reuters Health) - People who undergo liver transplantation, particularly children, are at increased risk for developing cancer, Finnish researchers report in the journal Liver Transplantation.
-
September 10, 2008
Survival rates rise in childhood blood cancers
WASHINGTON (Reuters) - Survival rates have improved in the United States for children with three common types of blood cancer since the 1990s, thanks to improved treatment, researchers in Germany said on Tuesday.
-
August 5, 2008
Cancer patients often use "complementary methods"
NEW YORK (Reuters Health) - In addition to conventional treatments aimed at improving survival, most cancer patients use "complementary methods" (CMs) to relieve symptoms and side effects and increase overall wellness, according to findings from a large study.
-
July 22, 2008
Technology uses tobacco plants to fight cancer
CHICAGO (Reuters) - A personalized vaccine made using tobacco plants -- normally associated with causing cancer rather than helping cure it -- could aid people with lymphoma in fighting the disease, U.S. researchers said on Monday.
-
June 19, 2008
Study finds weight-loss surgery cuts cancer risk
WASHINGTON (Reuters) - Morbidly obese patients who undergo weight-loss surgery greatly reduce their risk of cancer, according to a study providing fresh evidence of health benefits from these increasingly common operations.
-
May 16, 2008
Heart risks high in childhood cancer survivors
CHICAGO (Reuters) - Children who survive cancer while they are young are five to 10 times more likely than their healthy siblings to develop heart disease, U.S. researchers said on Thursday.
-
April 11, 2008
Smoking, drinking imperil lymphoma survival
NEW YORK (Reuters Health) - Smoking and moderate-to-high alcohol consumption negatively affect the survival of people with non-Hodgkin lymphoma, dubbed NHL, a European study shows.
-
March 21, 2008
Cephalon wins U.S. approval for leukemia drug
WASHINGTON (Reuters) - Cephalon Inc won U.S. approval to sell a chemotherapy drug to treat patients with a slow-growing type of leukemia, the company said on Thursday.
-
March 14, 2008
Many lymphoma survivors have psychological scars
NEW YORK (Reuters Health) - Almost 40 percent of survivors of non-Hodgkin's lymphoma report some degree of emotional distress in the years after diagnosis, according to North Carolina-based researchers.
-
March 12, 2008
Thyroid cancer patients at risk of second cancer
NEW YORK (Reuters Health) - After treatment for thyroid cancer, patients may face a slightly increased risk of developing a second primary malignancy elsewhere in the body, research suggests.
-
March 10, 2008
Non-Hodgkin's cancer patients living longer: study
CHICAGO (Reuters) - Improved treatments for non-Hodgkin's lymphoma helped patients live longer in the United States, researchers said on Monday.
-
February 26, 2008
Hepatitis C: a risk factor for lymphoma
NEW YORK (Reuters Health) - Canadian researchers have confirmed an association between hepatitis C virus (HCV) infection and an increased risk of non-Hodgkin's lymphoma, according to their report in the International Journal of Cancer.
-
February 15, 2008
British researchers link obesity to more cancers
LONDON (Reuters) - Obesity can double the risk of several cancers, according to a study published on Friday that for the first time also links being overweight with a number of less common forms of the disease.
-
February 14, 2008
Cancer drug slows multiple sclerosis
BOSTON (Reuters) - Two infusions of the cancer drug Rituxan given 2 weeks apart slowed the progression of multiple sclerosis for nearly 1 year, researchers reported on Wednesday.
-
February 14, 2008
Cancer drug slows multiple sclerosis
BOSTON (Reuters) - Two infusions of the cancer drug Rituxan given 2 weeks apart slowed the progression of multiple sclerosis for nearly 1 year, researchers reported on Wednesday.
-
January 4, 2008
Deformities common among kids with cancer
NEW YORK (Reuters Health) - Children with cancer are more likely than other children to have a variety of deformities, such as droopy eyelids and legs of different lengths, new research shows. This suggests that there are genetic defects or early prenatal environmental factors that influence the occurrence of both problems.
-
January 1, 2008
Some sun may guard against non-Hodgkin's lymphoma
NEW YORK (Reuters Health) - Recreational sun exposure could help prevent a type of blood cancer involving the lymph nodes called non-Hodgkin's lymphoma (NHL), according to pooled data from 10 studies.
-
December 10, 2007
Experimental drug works in type of leukemia
NEW YORK (Reuters) - Cephalon Inc's experimental cancer drug Treanda was significantly more effective than a common chemotherapy agent in helping patients with chronic lymphocytic leukemia (CLL) who had not received prior treatment achieve remission, according to a late-stage study.
-
December 10, 2007
Drug works in non-Hodgkin's lymphoma: study
NEW YORK (Reuters) - Cephalon Inc's experimental cancer drug Treanda appeared to be effective in patients whose non-Hodgkin's lymphoma (NHL) had progressed during or following treatment with Rituxan in a late-stage study, the company and researchers said on Saturday.
-
October 1, 2007
Lifestyle factors, obesity impact lymphoma risk
NEW YORK (Reuters Health) - Body size and patterns of smoking and drinking appear to modulate a person's risk of developing Hodgkin's and non-Hodgkin's lymphoma, a study shows.
-
August 9, 2007
Rituxan cures blistering skin disease: study
BOSTON (Reuters) - Four weekly injections of the cancer drug Rituxan may be enough to provide a long-term cure for a rare but potentially fatal skin disorder characterized by blistering lesions that do not heal, French researchers reported on Wednesday.
-
June 1, 2007
Sunlight exposure may increase lymphoma risk
NEW YORK (Reuters Health) - In women, ultraviolet radiation exposure from time spent in the sun appears to boost the risk of non-Hodgkin's lymphoma -- a type of cancer involving the body's lymphatic system, according to a large "population-based" study.
-
April 16, 2007
Amgen details higher death risk in Aranesp trial
LOS ANGELES (Reuters) - Amgen Inc. on Monday said 48.5 percent of cancer patients not undergoing chemotherapy or radiation who received its anemia drug Aranesp in a clinical trial died compared with 46 percent of patients on placebo as the company released details of a previously reported study.